CNS Disorders  >>  ADX71149 
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADX71149 / J&J, Addex
2020-003698-24: A study to investigate JNJ-40411813 in combination with levetiracetam in epilepsy

Ongoing
2
112
Europe
JNJ-40411813, JNJ-40411813, Tablet
Janssen-Cilag International NV, Janssen Research and Development LLC, US
Focal Onset Seizures, Seizures, Diseases [C] - Nervous System Diseases [C10]
 
 
NCT04836559 / 2020-003698-24: A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

Completed
2
110
Europe, US, RoW
JNJ-40411813, Placebo
Janssen Research & Development, LLC, Janssen Research and Development LLC, US
Focal Onset Seizures
02/24
02/24

Download Options